Monoclonal antibody-mediated modulation of the humoral immune response against mucosally applied Streptococcus mutans

Infection and Immunity

Volumn 68, Issue 4, 2000, Pages 1796-1805

  Brady, L Jeannine ^a   Van Tilburg, Marloes L J A ^a   Alford, Connie E ^a   McArthur, William P ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; FEMALE; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOMODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS MUTANS;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, BACTERIAL; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; MOUTH MUCOSA; SALIVA; STREPTOCOCCUS MUTANS; VAGINA;

EID: 0034122730     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.4.1796-1805.2000     Document Type: Article

References (87)

1. Ayakawa, G. Y., P. J. Boushell, P. J. Crowley, G. W. Erdos, W. P. McArthur, and A. S. Bleiweis. 1987. Isolation and characterization of monoclonal antibodies specific for antigen P1, a major surface protein of mutans streptococci. Infect. Immun. 55:2759-2767.
2. Berneman, A., L. Bele, V. A. Fischetti, and J. P. Bouvet. 1998. The specificity patterns of human immunoglobulin G antibodies in serum differ from those in autologous secretions. Infect. Immun. 66:4163-4168.
3. Booth, V., F. P. Ashley, and T. Lehner. 1996. Passive immunization with monoclonal antibodies against Porphyromonas gingivalis in patients with periodontitis. Infect. Immun. 64:422-427.
4. Bouige, P., S. Iscaki, A. Budkowska, A. Cosson, and J. Pillot. 1997. Interest of immunomodulation as a means to improve the preparation of polyclonal and monoclonal antibody reagents. J. Immunol. Methods 200:27-37.
5. Bouige, P., S. Iscaki, A. Cosson, and J. Pillot. 1996. Molecular analysis of the modulatory factors of the response to HBsAg in mice as an approach to HBV vaccine enhancement. FEMS Immunol. Med. Microbiol. 13:71-79.
6. Bouige, P., S. Iscaki, and J. Pillot. 1990. Immune complexes as immunizing agents to increase the number of monoclonal antibody producing hybrids and to deviate the response to poorly immunogenic epitopes. Hybridoma 9:519-526.
7. Brady, L. J., D. G. Cvitkovitch, C. M. Geric, M. N. Addison, J. C. Joyce, P. J. Crowley, and A. S. Bleiweis. 1998. Deletion of the central proline-rich repeat domain results in altered antigenicity and lack of surface expression of the Streptococcus mutans P1 adhesin molecule. Infect. Immun. 66:4274-4282.
8. Brady, L. J., D. A. Piacentini, P. J. Crowley, and A. S. Bleiweis. 1991. Identification of monoclonal antibody-binding domains with antigen P1 of Streptococcus mutans and cross-reactivity with related surface antigens of oral streptococci. Infect. Immun. 59:4425-4435.
9. Brady, L. J., D. A. Piacentini, P. J. Crowley, P. C. Oyston, and A. S. Bleiweis. 1992. Differentiation of salivary agglutinin-mediated adherence and aggregation of mutans streptococci by use of monoclonal antibodies against the major surface adhesin P1. Infect. Immun. 60:1008-1017.
10. Bratthall, D., R. Serinirach, K. Hamberg, and L. Widerstrom. 1997. Immunoglobulin A reaction to oral streptococci in saliva of subjects with different combinations of caries and levels of mutans streptococci. Oral Microbiol. Immunol. 12:212-218.
11. Brody, N. I., J. G. Walker, and G. W. Siskind. 1967. Studies on the control of antibody synthesis: interaction of antigenic competition and suppression of antibody formation by passive antibody on the immune response. J. Exp. Med. 126:81-91.
12. Casadevall, A., and M. D. Scharff. 1995. Return to the past: the case for antibody-based therapies in infectious diseases. J. Infect. Dis. 21:150-161.
13. Challacombe, S. J., L. A. Bergmeier, and A. S. Rees. 1984. Natural antibodies in man to a protein antigen from the bacterium Streptococcus mutans related to dental caries experience. Arch. Oral Biol. 29:179-184.
14. Coulie, P. G., and J. V. Snick. 1985. Enhancement of IgG anti-carrier responses by IgG2 anti-hapten antibodies in mice. Eur. J. Immunol. 15:793-798.
15. Crowley, P. J., L. J. Brady, D. A. Piacentini, and A. S. Bleiweis. 1993. Identification of a salivary agglutinin-binding domain within cell surface adhesin P1 of Streptococcus mutans. Infect. Immun. 61:1547-1552.
16. Forester, H., N. Hunter, and K. W. Knox. 1983. Characteristics of a high molecular weight extracellular protein of Streptococcus mutans. J. Gen. Microbiol. 129:2779-2788.
17. Fukuizumi, T., H. Inoue, T. Tsujisawa, and C. Uchiyama. 1997. Tonsillar application of killed Streptococcus mutans induces specific antibodies in rabbit saliva and blood plasma without inducing a cross-reacting antibody to human cardiac muscle. Infect. Immun. 65:4558-4563.
18. Hamada, S., T. Ooshima, T. Fijiwara, T. Minami, and S. Kimura. 1996. Development of preventative measures mased on the aetiology of dental caries: a review. Microb. Ecol. Health Dis. 9:349-357.
19. Hajishengallis, G., T. Koga, and M. W. Russell. 1994. Affinity and specificity of the interactions between Streptococcus mutans antigen I/II and salivary components. J. Dent. Res. 73:1493-1502.
20. Hajishengallis, G., and S. M. Michalek. 1999. Current status of a mucosal vaccine against dental caries. Oral Microbiol. Immunol. 14:1-20.
21. Hajishengallis, G., S. M. Michalek, and M. W. Russell. 1996. Persistence of serum and salivary antibody responses after oral immunization with a bacterial antigen genetically linked to the A2/B subunits of cholera toxin. Infect. Immun. 64:665-667.
22. Hajishengallis, G., M. W. Russell, and S. M. Michalek. 1998. Comparison of an adherence domain and a structural region of Streptococcus mutans antigen I/II in protective immunity against dental caries in rats after intranasal immunization. Infect. Immun. 66:1740-1743.
23. Harokopakis, E., G. Hajishengallis, T. E. Greenway, M. W. Russell, and S. M. Michalek. 1997. Mucosal immunogenicity of a recombinant Salmonella typhimurium-cloned heterologous antigen in the absence or presence of coexpressed cholera toxin A2 and B subunits. Infect. Immun. 65:1445-1454.
24. Harokopakis, E., G. Hajishengallis, and S. M. Michalek. 1998. Effectiveness of liposomes possessing surface-linked recombinant B subunit of cholera toxin as an oral antigen delivery system. Infect. Immun. 66:4299-4304.
25. Hatta, H., K. Tsuda, M. Ozeki, M. Kim, T. Yamamoto, S. Otake, M. Hirasawa, J. Katz, N. K. Childers, and S. M. Michalek. 1997. Passive immunization against dental plaque formation in humans: effect of a mouth rinse containing egg yolk antibodies (IgY) specific to Streptococcus mutans. Caries Res. 31:268-274.
26. Heyman, B. 1990. The immune complex: possible ways of regulating the antibody response. Immunol. Today 11:310-313.
27. Imbach, P., S. Barandun, H. Cottier, E. Gugler, A. Hassig, A. Morell, H. Wagner, and H. Heininger. 1990. Immunomodulation by intravenous immunoglobulin. Am. J. Pediatr. Hematol. Oncol. 12:134-140.
28. Iwaki, M., N. Okahashi, I. Takahashi, T. Kanamoto, Y. Sugita-Konishi, K. Aibara, and T. Koga. 1990. Oral immunization with recombinant Streptococcus lactis carrying the Streptococcus mutans surface protein antigen gene. Infect. Immun. 58:2929-2934.
29. Jackson, S., J. Mestecky, N. K. Childers, and S. M. Michalek. 1990. Liposomes containing anti-idiotypic antibodies: an oral vaccine to induce protective secretory immune responses specific for pathogens of mucosal surfaces. Infect. Immun. 58:1932-1936.
30. Jenkinson, H. F., and D. R. Demuth. 1997. Structure, function and immunogenicity of streptococcal antigen I/II polypeptides. Med. Microbiol. 23: 183-190.
31. Kelly, C. G., P. Evans, L. Bergmeier, S. F. Lee, A. Progulske-Fox, A. C. Harris, A. Aitken, A. S. Bleiweis, and T. Lehner. 1989. Sequence analysis of the cloned streptococcal cell surface protein antigen I/II. FEBS Lett. 258: 127-132.
32. Kelly, C. G., S. Todryk, H. L. Kendal, G. H. Munro, and R. Lehner. 1995. T-cell, adhesion, and B cell epitopes of the cell surface Streptococcus mutans protein antigen I/II. Infect. Immun. 63:3649-3658.
33. Kunkl, A., and G. G. B. Klaus. 1981. The generation of memory cells: immunization with antigen-antibody complex accelerates the development of B-memory cells, the formation of germinal centres and the maturation of antibody affinity in the secondary response. Immunology 43:371-378.
34. Kuntz, R. M., and W. M. Salzman. 1997. Polymeric controlled delivery for immunization. Trends Biotechnol. 15:364-369.
35. Kuo, P. Y., J. K. Sherwood, and W. M. Saltzman. 1998. Topical antibody delivery systems produce sustained levels in mucosal tissue and blood. Nat. Biotechnol. 16:163-167.
36. Laissue, J., H. Cottier, M. W. Hess, and R. D. Stoner. 1971. Early and enhanced germinal center formation and antibody response in mice after primary stimulation with antigen isologous antibody complex as compared with antigen alone. J. Immunol. 107:822-831.
37. Lanzavecchia, A. 1985. Antigen-specific interactions between T and B cells. Nature 314:537-545.
38. Lee, S. F., A. Progulske-Fox, and A. S. Bleiweis. 1988. Molecular cloning and expression of a Streptococcus mutans major surface protein antigen, P1 (I/II) in Escherichia coli. Infect. Immun. 56:2114-2119.
39. Lehner, T., M. W. Russell, J. Caldwell, and R. Smith. 1981. Immunization with purified protein antigens from Streptococcus mutans against dental caries in rhesus monkeys. Infect. Immun. 34:407-415.
40. Lehtonen, O. P., E. M. Grahn, T. H. Stahlberg, and L. A. Laitinen. 1984. Amount and avidity of salivary and serum antibodies against Streptococcus mutans in two groups of human subjects with differential dental caries susceptibility. Infect. Immun. 43:308-313.
41. Loesche, W. J. 1986. Role of Streptococcus mutans in human dental decay. Microbiol. Rev. 50:353-380.
42. Ma, J. K.-C., A. Hiatt, M. Hein, N. D. Vine, F. Wang, P. Stabila, C. van Dolleweerd, K. Mostov, and T. Lehner. 1995. Generation and assembly of secretory antibodies in plants. Science 268:716-719.
43. Ma, J. K.-C., B. Y. Hikmat, K. Wycoff, N. D. Vine, D. Chargelegue, L. Yu, M. B. Hein, and T. Lehner. 1998. Characterization of a recombinant plant monoclonal secretory antibody and preventative immunotherapy in humans. Nat. Med. 4:601-606.
44. Ma, J. K.-C., M. Hunjan, R. Smith, C. Kelly, and T. Lehner. 1990. An investigation into the mechanism of protection by local passive immunization with monoclonal antibodies against Streptococcus mutans. Infect. Immun. 58:3407-3414.
45. Manca, F. 1991. Interference of monoclonal antibodies with proteolysis of antigens in cellular and in acellular systems. Ann. Ist. Super. Sanita 27:15-20.
46. Manca, F., D. Fenoglio, G. Li Pira, A. Kunkl, and F. Celada. 1991. Effect of antigen/antibody ratio on macrophage uptake, processing, and presentation to T cells of antigen complexed with polyclonal antibodies. J. Exp. Med. 173:37-48.
47. Marusic, M., M. Marusic-Galesic, and B. Pokric. 1992. Humoral immune response to the antigen administered as an immune complex. Immunol. Investig. 21:623-628.
48. Matsushita, K., T. Nisizawa, S. Nagsaoka, M. Kawagoe, and T. Koga. 1994. Identification of antigenic epitopes in a surface protein antigen of Streptococcus mutans in humans. Infect. Immun. 62:4034-4042.
49. McGhee, J. R., and H. Kiyono. 1994. Effective mucosal immunity. Current concepts in vaccine delivery and immune response analysis. Int. J. Technol. Assess. Health Care 10:93-106.
50. Munro, G., P. Evans, S. Todryk, P. Buckett, C. G. Kelly, and T. Lehner. 1993. A protein fragment of streptococcal cell surface antigen I/II which prevents adhesion of Streptococcus mutans. Infect. Immun. 61:4590-4598.
51. Nie, X., S. Basu, and J. Cerny. 1997. Immunization with immune complex alters the repertoire of antigen-reactive B cells in the germinal centers. Eur. J. Immunol. 27:3517-3525.
52. Okahashi, N., C. Sasakawa, M. Yoshikawa, S. Hamada, and T. Koga. 1989. Cloning of a surface protein antigen from serotype c Streptococcus mutans. Mol. Microbiol. 3:221-228.
53. Okahashi, N., C. Sasakawa, M. Yoshikawa, S. Hamada, and T. Koga. 1989. Molecular characterization of a surface protein antigen gene from serotype c Streptococcus mutans, implicated in dental caries. Mol. Microbiol. 3:673-678.
54. Pincus, C. A., and V. Nussenzweig. 1969. Passive antibody may simultaneously suppress and stimulate antibody formation against different portions of a protein molecule. Nature 222:594-596.
55. Pokric, B., D. Sladic, S. Juros, and S. Cajavec. 1992. Application of the immune complex for immune protection against viral disease. Vaccine 11: 655-659.
56. Quiding-Jarbrink, M., M. Lakew, I. Nordstrom, J. Banchereau, E. Butcher, J. Holmgren, and C. Czerkinsky. 1995. Human circulating specific antibody-forming cells after systemic and mucosal immunizations: differential homing commitments and cell surface differentiation markers. Eur. J. Immunol. 25:322-327.
57. Quiding-Jabrink, M., I. Nordstrom, G. Granstorm, A. Kilander, M. Jertborn, E. C. Butcher, A. I. Lazarovits, J. Holmgren, and C. Czerkinsky. 1997. Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations: a molecular basis for the compartmentalization of effector B cell responses. J. Clin. Investig. 99:1281-1286.
58. Ramisse, F., P. Binder, M. Szatanik, and J.-M. Alonso. 1996. Passive and active immunotherapy for experimental pneumococcal pneumonia by polyvalent human immunoglobulin or F(ab′)2 fragments administered intranasally. J. Infect. Dis. 173:1123-1128.
59. Ramisse, F., M. Szatanik, P. Binder, and J.-M. Alonso. 1993. Passive local immunotherapy of experimental staphylococcal pneumonia with human intravenous immunoglobulin. J. Infect. Dis. 168:1030-1033.
60. Redman, T. K., C. C. Harmon, R. L. Lallone, and S. M. Michalek. 1995. Oral immunization with recombinant Salmonella typhimurium expressing surface protein antigen A of Streptococcus sobrinus: dose response and induction of protective humoral responses in rats. Infect. Immun. 63:2004-2011.
61. Russell, M. W., G. Hajishengallis, N. K. Childers, and S. M. Michalek. 1999. Secretory immunity in defense against cariogenic mutans streptococci. Caries Res. 33:4-15.
62. Russell, M. W., and T. Lehner. 1978. Characterization of antigens extracted from cells and culture fluids of Streptococcus mutans serotype c. Arch. Oral Biol. 23:7-15.
63. Russell, M. W., Z. Moldoveanu, P. L. White, G. J. Sibert, J. Mestecky, and S. M. Michalek. 1996. Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the cholera toxin B subunit. Infect. Immun. 64:1272-1283.
64. Russell, M. W., and H. Y. Wu. 1991. Distribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen I/II of Streptococcus mutans coupled to cholera toxin subunit. Infect. Immun. 59:4061-4070.
65. Russell, M. W., H. Y. Wu, P. L. White, I. Takahashi, N. Okahashi, and T. Koga. 1992. Peroral immunization with a cholera toxin-linked bacterial protein antigen and synthetic peptide, p. 199-207. In J. E. Ciardi et al. (ed.), Genetically engineered vaccines. Plenum Press, New York, N.Y.
66. Russell, R. R. B. 1979. Wall associated antigens of Streptococcus mutans. J. Gen. Microbiol. 114:109-115.
67. Senpuku, H., T. Miyauchi, N. Hanada, and T. Nisizawa. 1995. An antigenic peptide inducing cross-reacting antibodies inhibiting the interaction of Streptococcus mutans PAc with human salivary components. Infect. Immun. 63: 4695-4703.
68. Sinclair, N. R. 1979. Modulation of immunity by antigen-antibody complexes and antigen. Pharmacol. Ther. 4:355-432.
69. Smitsek, P. S., D. G. Campbell, A. Lanzavecchia, N. Fairweather, and C. Watts. 1995. Modulation of antigen processing by bound antibodies can boost or suppress class 1 major histocompatability complex presentation of different T cell determinants. J. Exp. Med. 181:1957-1963.
70. Stenbaek, E. 1992. Use of passive immunization for the production of monoclonal antibodies against Actinobacillus pleuropneumoniae serotypes 1, 6, and 12. J. Immunol. Methods 156:267-269.
71. Takahashi, I., N. Okahashi, K. Matsushita, M. Tokuda, T. Kanamoto, E. Munekata, M. W. Russell, and T. Koga. 1991. Immunogenicity and protective effect against oral colonization by Streptococcus mutans of synthetic peptides of a streptococcal surface protein antigen. J. Immunol. 146:332-336.
72. Teitelbaum, R., A. Glatman-Freedman, B. Chen, J. B. Robbins, E. Unanue, A. Casadevall, and B. R. Bloom. 1998. A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival. Proc. Natl. Acad. Sci. USA 95:15688-15693.
73. Terres, G., and W. Wolins. 1961. Enhanced immunological sensitization of mice by the simultaneous injection of antigen and specific antiserum. J. Immunol. 86:311-368.
74. Tenovuo, J., and A. A. Aaltonen. 1991. Antibody responses to mutans streptococci in children. Proc. Finn. Dent. Soc. 87:449-461.
75. Thalhamer, J., and J. Freund. 1985. Passive immunization: a method of enhancing the immune response against antigen mixtures. J. Immunol. Methods 80:7-13.
76. Todryk, S. M., C. G. Kelly, and C. G. Lehner. 1998. Effect of route of immunisation and adjuvant on T and B cell epitope recognition within a streptococcal antigen. Vaccine 16:174-180.
77. Toida, N., G. Hajishengallis, H.-Y. Wu, and M. W. Russell. 1997. Oral immunization with the saliva-binding region of Streptococcus mutans AgI/II genetically coupled to the cholera toxin B subunit elicits T-helper-cell responses in gut-associated lymphoid tissue. Infect. Immun. 65:909-915.
78. Uhr, J. W., and J. B. Baumann. 1961. Antibody formation: the suppression of antibody formation by passively administered antibody. J. Exp. Med. 113:935-957.
79. Waldmann, H. 1989. Manipulation of T-cell responses with monoclonal antibodies. Annu. Rev. Immunol. 7:407-444.
80. Wiersma, E. J., P. G. Coulie, and B. Heyman. 1989. Dual immunoregulatory effects of monoclonal IgG antibodies: suppression and enhancement of the antibody response. Scand. J. Immunol. 29:439-448.
81. Willett, B. J., A. de Parseval, E. Peri, M. Rocchi, M. J. Hosie, R. Randall, D. Klatzmann, J. C. Neil, and O. Jarrett. 1994. The generation of monoclonal antibodies recognising novel epitopes by immunisation with solid matrix antigen-antibody complexes reveals a polymorphic determinant on feline CD4. J. Immunol. Methods 176:213-220.
82. Wu, H. Y., H. H. Nguyen, and M. W. Russell. 1997. Nasal lymphoid tissue (NALT) as a mucosal immune inductive site. Scand. J. Immunol. 46:506-513.
83. Wu, H. Y., and M. W. Russell. 1993. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect. Immun. 61:314-322.
84. Wu, H. Y., and M. W. Russell. 1994. Comparison of systemic and mucosal priming for mucosal immune responses to a bacterial protein antigen given with or coupled to cholera toxin (CT) B subunit, and effects of pre-existing anti-CT immunity. Vaccine 12:215-223.
85. Wu, H. Y., and M. W. Russell. 1998. Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant. Vaccine 16:286-292.
86. Yuan, R., A. Casadevall, J. Oh, and M. D. Scharff. 1997. T cells cooperate with passive antibody to modify Cryptotoccus neoformans infection in mice. Proc. Natl. Acad. Sci. USA 94:2483-2488.
87. Yuan, R., A. Casadevall, G. Spira, and M. D. Scharff. 1995. Isotype switching from IgG3 to IgG1 converts a nonprotective murine antibody to Cryptococcus neoformans into a protective antibody. J. Immunol. 154:1810-1816.